Search
Search
Close this search box.

Cannabis Sales Hit Record Highs in Connecticut and Arkansas

June 2023 saw Connecticut and Arkansas hit record highs for its cannabis sales.

In Connecticut, medical and recreational cannabis sales hit almost $24 million – and the month also saw adult use sales higher than medical sales. The adult-use market in saw $12.5 million in cannabis sales following the launch of adult use sales on January 10, 2023, and $11.3 million in medical.

According to KNWA, Arkansas patients also spent USD$141 million in June – a new record for the state.

In a statement, Arkansas’ Department of Finance and Administration spokesperson Scott Hardin stated: “With a sales average of $23.5 million monthly, we should surpass $1 billion in overall sales toward the end of this year.”

READ MORE: Cannabis Legalisation Bill Put Forward in Pennsylvania

The Connecticut Department of Consumer Protection has also confirmed that the average product price for medical marijuana patients was $37.43 in June, while the average price of adult-use products was $40.00.

The Department also released new data containing additional information about the types of products sold by dollar amount, showing that, in the first six months of sales, 53% of sales were usable cannabis, or flower, while vapes made up 25% of sales and edible products represented 10% of sales.

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?